Hippocratic AI secures $126 million Series C to expand generative healthcare agent network

Hippocratic AI, a leader in generative medical agents, raised $126 million in a Series C round led by Avenir, valuing the company at $3.4 billion. The funding will scale its patient-communication and triage products, which use large language models to improve healthcare delivery. The company plans to expand clinical integrations and data-governance infrastructure across major U.S. hospital networks. Analysts said the deal underscores investor confidence in specialized, safety-focused medical AI platforms positioned at the intersection of automation and healthcare regulation.